PuSH - Publikationsserver des Helmholtz Zentrums München

De Angelis, M ; Maity-Kumar, G. ; Schriever, S.C. ; Kozlova, E.V.* ; Müller, T.D. ; Pfluger, P.T. ; Curras-Collazo, M.C.* ; Schramm, K.-W.

Development and validation of an LC-MS/MS methodology for the quantification of thyroid hormones in dko MCT8/OATP1C1 mouse brain.

J. Pharm. Biomed. Anal. 221:115038 (2022)
Postprint DOI PMC
Open Access Green
The Allan-Herndon Dudley Syndrome (AHDS) is a rare disease caused by the progressive loss of monocarboxylate transporter 8 (MCT8). In patients with AHDS, the absence of MCT8 impairs transport of thyroid hormones (TH) through the blood brain barrier, leading to a central state of TH deficiency. In mice, the AHDS is mimicked by simultaneous deletion of the TH transporters MCT8 and the solute carrier organic anion transporter family member 1c1 (OATP1C1). To support preclinical mouse studies, an analytical methodology was developed and successfully applied for quantifying selected thyroid hormones in mouse whole brain and in specific regions using liquid chromatography tandem mass-spectrometry (LC-MS/MS). An important requirement for the methodology was its high sensitivity since a very low concentration of THs was expected in MCT8/OATP1C1 double-knockout (dko) mouse brain. Seven THs were targeted: L-thyroxine (T4), 3,3´,5‐triiodo‐L‐thyronine-thyronine (T3), 3,3´,5´‐triiodo‐L‐thyronine-thyronine (rT3), 3,3´‐diiodo‐L‐thyronine (3,3´‐T2, T2), 3,5-diiodo-L-thyronine (rT2, 3,5-T2), 3-iodo-L-thyronine (T1), 3-iodothyronamine (T1AM). Isotope dilution liquid chromatography triple-quadrupole mass spectrometry methodology was applied for detection and quantification. The method was validated in wild-type animals for mouse whole brain and for five different brain regions (hypothalamus, hippocampus, prefrontal cortex, brainstem and cortex). Instrumental calibration curves ranged from 0.35 to 150 pg/µL with good linearity (r2 >0.996). The limit of quantification was from 0.08 to 0.6 pg/mg, with an intra- and inter-day precision of 4.2–14.02% and 0.4–17.9% respectively, and accuracies between 84.9% and 114.8% when the methodology was validated for the whole brain. In smaller, distinct brain regions, intra- and inter-day precision were 0.6–20.7% and 2.5–15.6% respectively, and accuracies were 80.2–128.6%. The new methodology was highly sensitive and allowed for the following quantification in wild-type mice: (i) for the first time, four distinct thyroid hormones (T4, T3, rT3 and 3,3´‐T2) in only approximately 100 mg of mouse brain were detected; (ii) the quantification of T4 and T3 for the first time in distinct mouse brain regions were reported. Further, application of our method to MCT8/OATP1C1 dko mice revealed the expected, relative lack of T3 and T4 uptake into the brain, and confirmed the utility of our analytical method to study TH transport across the blood brain barrier in a preclinical model of central TH deficiency.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter 3,3´,5-triiodo-l-thyronine (t3) ; 3,3´,5´-triiodo-l-thyronine (rt3) ; 3,3´-diiodo-l-thyronine (3,3´-t2) ; Dko Mct8/oatp1c1 Mouse Brain ; L-thyroxine (t4) ; Liquid Chromatography-mass Spectrometry
ISSN (print) / ISBN 0731-7085
e-ISSN 0731-7085
Zeitschrift Journal of Pharmaceutical and Biomedical Analysis : JPBA
Quellenangaben Band: 221, Heft: , Seiten: , Artikelnummer: 115038 Supplement: ,
Verlag Elsevier
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) PPM-MEX-Molecular EXposomics (MEX)
Institute of Diabetes and Obesity (IDO)